Literature DB >> 34602353

The role of the nasopharyngeal prong in craniofacial disorders in particular the Pierre Robin sequence.

Francois Abel1, Colin Wallis2.   

Abstract

There are a wide range of surgical and maxillofacial options to alleviate upper airway obstruction in children with craniofacial disorders. The nasopharyngeal prong (NPP) is a simple idea where the airway obstruction arising from the posteriorly placed tongue secondary to a small mandible can be overcome quickly and without resorting to more invasive surgical procedures. The role of the NPP is of particular interest in Robin sequence (RS). RS describes a congenital anomaly with retrognathia (often with associated U-shaped cleft palate) where in some children the tongue and small jaw can significantly impact on airway patency with upper airway obstruction. The NPP is a modified endotracheal tube, of ideal diameter and cut to a desired length that can bypass the airway obstruction and regain patency to the upper airway. RS has a natural history of mandibular growth and resolution of the symptoms with time and thus the NPP presents a medium term solution precluding the need in selected children of more permanent and potentially unnecessary surgical procedures. The role of the NPP in other craniofacial disorders (either as a temporary solution or longer term option) requires further research.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Micrognathia; Nasopharyngeal prong; Pierre Robin management; Robin sequence; Syndrome airway obstruction

Mesh:

Year:  2021        PMID: 34602353     DOI: 10.1016/j.siny.2021.101285

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  1 in total

1.  Humidified versus nonhumidified low-flow oxygen therapy in children with Pierre-Robin syndrome: A randomized controlled trial.

Authors:  Xin Zhang; Aijuan Fan; Yingfei Liu; Li Wei
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.